Written by Klarity Editorial Team
Published: May 24, 2026

You’re licensed, trained, and ready to treat anxiety — but can you actually prescribe the medications your patients need? If you’re a psychiatric nurse practitioner (PMHNP) or psychiatrist navigating telehealth, state regulations, and controlled substance rules, the answer isn’t always straightforward.
Here’s the reality: Psychiatrists can prescribe any anxiety medication in any state. PMHNPs? It depends entirely on where you’re licensed.
Some states grant full independence. Others require physician collaboration agreements. A few still restrict what you can prescribe, how much, and under what supervision. And if you’re practicing via telehealth — which most anxiety providers are now doing — federal and state telemedicine rules add another layer.
This guide breaks down exactly what psychiatrists and PMHNPs can prescribe for anxiety, state-by-state differences in scope of practice, federal telehealth prescribing rules (extended through 2026), and what it means for your practice.
Short answer: Yes — through at least December 2026.
The Ryan Haight Act historically required an in-person visit before prescribing controlled substances like benzodiazepines. COVID-19 changed that. The DEA and HHS suspended the requirement in 2020, and as of February 2026, that flexibility remains in effect through December 2026.
What this means practically:
The DEA is working on permanent regulations expected later in 2026. Stay alert — future rules may require a special telemedicine registration or periodic in-person visits. But for now, telehealth prescribing of anxiety meds is fully legal at the federal level.
Most states align with federal rules, but some add conditions:
Florida explicitly allows teleprescribing of Schedule II drugs (like stimulants) for psychiatric disorders — meaning you can manage anxiety with comorbid ADHD via telehealth. You must check Florida’s PDMP (E-FORCSE) before prescribing any controlled substance.
Texas bans telemedicine treatment of chronic pain with controlled substances, but anxiety treatment is permitted. Texas requires a valid patient-practitioner relationship via live audio-visual exam before prescribing.
California, New York, Pennsylvania, Illinois — no unique telehealth prescribing restrictions beyond federal law. All require PDMP checks before prescribing controlled anxiolytics.
Bottom line: If you’re licensed in the state, follow standard-of-care evaluation procedures via video, and check the state PDMP, you can prescribe anxiety medications — including controlled substances — via telehealth.
This is where state law creates real differences.
You can prescribe any anxiety medication in all 50 states. No supervision. No collaborative agreements. No quantity limits (beyond standard medical practice and DEA scheduling).
Whether it’s an SSRI for generalized anxiety, a benzodiazepine for panic disorder, or off-label use of other medications, your prescriptive authority is unrestricted.
PMHNPs are highly trained psychiatric medication managers — but your legal authority to prescribe anxiety meds varies dramatically by state.
Full Practice Authority (FPA) States
In about half of U.S. states, PMHNPs can evaluate, diagnose, and prescribe medications independently — including controlled substances. Your authority is essentially equivalent to a psychiatrist’s.
Examples:
Reduced/Restricted Practice States
The other half require PMHNPs to maintain a collaborative agreement with a physician (often a psychiatrist) to prescribe.
California
Texas
Florida
Pennsylvania
Illinois
If you’re a PMHNP in New York, you have the same prescriptive freedom as a psychiatrist.
If you’re in Texas or Pennsylvania, you’ll need to find a collaborating psychiatrist — and that relationship defines what you can prescribe, especially controlled substances.
If you’re in California or Illinois, you’re on a transition pathway — restricted initially, but with a clear route to independence after meeting experience requirements.
For telehealth platforms: This is why many companies either (a) pair NPs with physician collaborators in restricted states, or (b) focus recruitment in FPA states where regulations are simpler.
| Provider Type | Can Prescribe Benzodiazepines? | Can Prescribe Schedule II (e.g., stimulants for comorbid ADHD)? | Requires Physician Collaboration? |
|---|---|---|---|
| Psychiatrist (MD/DO) | Yes, all states | Yes, all states | No |
| PMHNP (FPA state) | Yes, independently | Yes, independently | No |
| PMHNP (CA, transitioning) | Yes, with protocol (until 104 NP) | Yes, with protocol | Yes (until 104 NP status) |
| PMHNP (TX) | Yes, if authorized in agreement | No (hospital/hospice only) | Yes, mandatory |
| PMHNP (FL) | Yes (>7 days if psych NP for mental disorder) | Yes (>7 days if psych NP) | Yes, written protocol |
| PMHNP (PA) | Yes, if authorized in agreement | Yes, with physician co-sign | Yes, mandatory |
| PMHNP (IL, with FPA) | Yes (after physician attestation) | Yes (after physician attestation) | No (after FPA achieved) |
Understanding reimbursement helps you evaluate telehealth opportunities and set realistic income expectations.
90792 — Psychiatric diagnostic evaluation with medical services
Medicare 2026: ~$202
Medicaid: ~$85
Private insurance: $150-$250
99213 — 15-minute established patient medication follow-up
Medicare 2026: ~$95
Medicaid: ~$40-50
Private insurance: $80-$130
99214 — 25-minute moderate complexity visit
Medicare 2026: ~$136
Medicaid: ~$65-75
Private insurance: $120-$180
90833 — Psychotherapy add-on (30 minutes)
Medicare 2026: ~$81
Medicaid: ~$40
Private insurance: ~$80-100
Medicare pays PMHNPs at 85% of physician rates for the same service. If a psychiatrist gets $100 for a med check, an NP gets $85.
Most private insurers follow similar patterns. Some state Medicaid programs pay NPs and physicians equally, but many discount NP rates by 10-15%.
This doesn’t mean NPs earn less overall — platforms and practices often compensate by giving NPs higher patient volume or adjusting base salaries to account for the reimbursement difference.
Good news: Most states now require insurers to pay the same rate for telehealth visits as in-person visits.
California (AB 744), Illinois, and New York have explicit telehealth parity laws. Texas doesn’t mandate parity, but many insurers voluntarily pay equivalent rates for mental health telehealth.
Medicare extended telehealth payment parity through at least September 2025, with likely extensions into 2026. This means you earn the same for a video visit as you would for an in-office appointment.
One Medicare caveat: Outside of pandemic flexibilities, Medicare was set to require periodic in-person visits (within 6 months) for tele-mental health services. Congress has repeatedly delayed this rule — it’s not actively enforced in 2026, but check for updates if you primarily see Medicare patients via telehealth.
Here’s what most providers don’t talk about: the true cost of acquiring a qualified psychiatric patient on your own.
SEO: 6-12 months of consistent investment before you see meaningful patient flow. You need content creation, technical optimization, and backlink building — plus either your time or $2,000-5,000/month for an agency. Most solo providers don’t have the expertise or budget.
Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. Factor in ad spend, testing, optimization, and you’re looking at $200-400+ per booked patient — and that’s if you know what you’re doing.
Directory Listings: Psychology Today, Zocdoc, and similar platforms charge monthly subscription fees ($30-100+) PLUS compete you against hundreds of other providers on the same page. Zocdoc charges $35-100 per booking on top of the monthly fee. Your total monthly cost adds up fast.
Agency/Consultant Fees: If you hire someone to handle your marketing, expect $1,500-3,000/month minimum. Add ad spend on top.
Staff Time: Someone has to handle inquiries, qualify leads, schedule appointments, and follow up on no-shows. Cold leads from generic advertising have higher no-show rates than platform-matched patients.
All-in Cost: When you factor in ALL costs — agency fees, ad spend, staff time, no-shows, months of investment before results — acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ per patient.
And you’re gambling. You don’t know if your SEO will rank. You don’t know if your ads will convert. You’re paying whether patients book or not.
Klarity uses a pay-per-appointment model — you pay a standard listing fee when a new patient books with you. No upfront marketing spend. No monthly subscriptions. No wasted ad budget.
What you get:
The economic case: Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay a fee per patient and get guaranteed ROI. Every dollar you spend directly correlates to a patient on your schedule.
For providers starting out or scaling up, this removes the biggest barrier to building a practice: finding patients. You focus on delivering great care. The platform handles patient acquisition.
| State | NP Scope of Practice | Controlled Substance Authority | Telehealth Prescribing Notes |
|---|---|---|---|
| California | Reduced → Full (transition via 103/104 NP pathway) | Yes, with protocol → independent after 104 NP | No state restrictions; follows federal rules |
| Texas | Restricted (requires physician agreement) | Yes for Schedule IV (benzos); No for Schedule II outpatient | Chronic pain treatment banned; anxiety allowed |
| Florida | Reduced (requires written protocol) | Yes; 7-day limit on Schedule II unless psychiatric NP | Schedule II allowed for psych disorders via telehealth |
| New York | Full Practice Authority (since 2022) | Yes, independently | PDMP check required for all controlled substances |
| Pennsylvania | Restricted (collaborative agreement required) | Yes, with physician oversight | Physician must co-sign Schedule II within 24 hours |
| Illinois | Reduced → Full (after 4,000 hours + 250 CE) | Yes; physician attestation needed for benzos/Schedule II even with FPA | Strong telehealth parity laws |
Can a psychiatric nurse practitioner prescribe benzodiazepines?
Yes, in all 50 states — but you may need a collaborative agreement with a physician depending on your state’s scope of practice laws. In Full Practice Authority states (NY, AZ, OR, etc.), PMHNPs can prescribe benzodiazepines independently. In restricted states (TX, PA, FL), you need physician oversight or a written protocol authorizing controlled substance prescribing.
Can psychiatrists prescribe anxiety medication via telehealth without seeing the patient in person?
Yes. Federal telehealth flexibilities (extended through December 2026) allow psychiatrists to prescribe controlled substances, including benzodiazepines, via video visits without an initial in-person exam. This applies in all states, though you must comply with state PDMP requirements and telehealth practice standards.
Do I need a DEA license to prescribe anxiety medications?
You need a DEA registration to prescribe controlled substances (benzodiazepines are Schedule IV). You do NOT need a DEA license to prescribe non-controlled anxiety medications like SSRIs, SNRIs, or buspirone. All providers (MD, DO, NP) must apply for DEA registration separately from their medical/nursing license.
What’s the difference between a psychiatrist and PMHNP for anxiety treatment?
In Full Practice Authority states, there’s functionally no difference in prescribing — both can independently manage all anxiety medications. In restricted states, PMHNPs need physician collaboration, which may limit what they can prescribe or require oversight. Reimbursement also differs slightly (Medicare pays NPs at 85% of physician rates).
Can I prescribe controlled substances across state lines via telehealth?
Only if you’re fully licensed in the state where the patient is located. You must follow that state’s prescribing rules, check that state’s PDMP, and comply with both federal telemedicine rules and state telehealth laws. Some states offer out-of-state telehealth registrations, but these typically do not allow controlled substance prescribing (e.g., Florida’s telehealth provider registration).
What happens when the federal telehealth flexibilities expire?
The DEA is expected to issue permanent telemedicine prescribing regulations by late 2026. These may require a special telemedicine DEA registration or periodic in-person visits for certain controlled substances. The current extension through December 2026 gives regulators time to finalize rules that balance access with patient safety.
How much can I earn doing telehealth medication management for anxiety?
Medicare pays ~$95 for a 15-minute follow-up (99213) and ~$202 for an initial evaluation (90792). Private insurance typically pays $80-$180 per visit depending on complexity. If you see 20 patients per week at an average of $100 per visit, that’s $8,000/month in gross revenue before platform fees or practice costs. Telehealth platforms vary in how they compensate — some pay per visit, others use hourly or salary models.
Access to more patients without marketing costs. Platforms like Klarity handle patient acquisition — you get matched with pre-qualified patients ready to book. No SEO, no Google Ads, no directory fees.
Simplified compliance. The platform manages HIPAA-compliant video infrastructure, credentialing, and often billing. You focus on clinical care, not admin.
Flexible schedule. Set your own hours. See patients across multiple states (if you’re licensed) from home or anywhere with internet.
Better economics than DIY. Instead of gambling $3,000-5,000/month on marketing, you pay only when you see a patient. Guaranteed ROI.
Both insurance and cash-pay patients. Platforms typically offer both revenue streams — you’re not locked into one payer type.
For psychiatrists and PMHNPs treating anxiety, telehealth platforms remove the biggest barriers to building a practice: finding patients, managing technology, and handling billing. You get to do the work you were trained for — helping people with anxiety disorders — without the overhead of running a traditional practice.
If you’re a psychiatrist or PMHNP looking to expand your practice, reach more patients, and avoid the high costs and uncertainty of DIY marketing, joining a telehealth platform is the smart economic choice.
Klarity Health offers:
Ready to see more patients? Explore Klarity’s provider network and start treating anxiety patients on your terms — with guaranteed patient flow and no marketing risk.
HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (www.hhs.gov/press-room/dea-telemedicine-extension-2026.html)
Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (www.flsenate.gov/laws/statutes/2024/464.012, www.flsenate.gov/laws/statutes/2022/456.47)
California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov/practice/ab890.shtml)
NPNY announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes)
TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (therathink.com/insurance-reimbursement-rates-for-psychiatrists)
Find the right provider for your needs — select your state to find expert care near you.